[1] N.A. Khan, Acanthamoeba: Biology and increasing importance in human health,
FEMS Microbiol. Rev. 30 (2006) 564–595, https://doi.org/10.1111/j.1574-6976.
2006.00023.x.
[2] M.M. Juárez, L.I. Tártara, A.G. Cid, J.P. Real, J.M. Bermúdez, V.B. Rajal,
S.D. Palma, Acanthamoeba in the eye, can the parasite hide even more? Latest
developments on the disease, Contact Lens Anterior Eye 41 (2018) 245–251,
https://doi.org/10.1016/j.clae.2017.12.017.
[3] J.K.G. Dart, V.P.J. Saw, S. Kilvington, Acanthamoeba Keratitis: Diagnosis and
Treatment Update 2009, Am. J. Ophthalmol. 148 (2009) 487–499, https://doi.org/
10.1016/j.ajo.2009.06.009 e2.
[4] J. Lorenzo-Morales, N.A. Khan, J. Walochnik, An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment, Parasite 22 (2015) 10, https://doi.org/
10.1051/parasite/2015010.
[5] H. Nakagawa, T. Hattori, N. Koike, T. Ehara, K. Fujita, H. Takahashi, S. Kumakura,
M. Kuroda, T. Matsumoto, H. Goto, Investigation of the role of bacteria in the development of Acanthamoeba Keratitis, Cornea 34 (2015) 1308–1315, https://doi.
org/10.1097/ICO.0000000000000541.
[6] P. Agostinis, K. Berg, K.A. Cengel, T.H. Foster, A.W. Girotti, S.O. Gollnick,
S.M. Hahn, M.R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz,
D. Nowis, J. Piette, B.C. Wilson, J. Golab, Photodynamic therapy of cancer: an
update, CA Cancer J. Clin. 61 (2011) 250–281, https://doi.org/10.3322/caac.
20114.
[7] R.R. Allison, K. Moghissi, Oncologic photodynamic therapy: clinical strategies that
modulate mechanisms of action, Photodiagn. Photodyn. Ther. 10 (2013) 331–341,
https://doi.org/10.1016/j.pdpdt.2013.03.011.
[8] L. De Sordi, M.A. Butt, H. Pye, D. Kohoutova, C.A. Mosse, G. Yahioglu, I. Stamati,
M. Deonarain, S. Battah, D. Ready, E. Allan, P. Mullany, L.B. Lovat, Development of
Photodynamic Antimicrobial Chemotherapy (PACT) for clostridium difficile, PLoS
One 10 (2015) 1–17, https://doi.org/10.1371/journal.pone.0135039.
171
...
論文の公開元へ
